1501 — Shanghai INT Medical Instruments Co Income Statement
0.000.00%
Last trade - 00:00- HK$8.23bn
- HK$8.41bn
- CNY1.07bn
Annual income statement for Shanghai INT Medical Instruments Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 465 | 586 | 753 | 852 | 1,065 |
| Cost of Revenue | |||||
| Gross Profit | 276 | 332 | 438 | 538 | 637 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 308 | 441 | 575 | 636 | 794 |
| Operating Profit | 156 | 145 | 178 | 216 | 271 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 156 | 144 | 175 | 213 | 258 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 140 | 134 | 153 | 190 | 233 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 143 | 132 | 156 | 192 | 219 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 143 | 132 | 156 | 181 | 206 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.857 | 0.782 | 0.916 | 1.1 | 1.26 |
| Dividends per Share |